Mechanically, upregulated PD-L1 on the surface of tumor cells can bind to the programmed cell death protein 1 (PD1) which is presented on tumor-infiltrating lymphocytes and subsequently cause blockade of T cell activation and protect tumor cells from T cell-mediated killing [8]. The gene discussed is PDCD1; the disease is neoplasm.